Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
Is there A Genetic Correlation between Multiple Sclerosis and Cerebral Aneurysms?
Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple Sclerosis.
Antiphospholipid antibodies: paradigm in transition.
Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
Microglia, physiology and behavior: A brief commentary.
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence.
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury.
Structural correlates for fatigue in early relapsing remitting multiple sclerosis.
Autopsy-proven demyelination associated with infliximab treatment.
Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Conformational Changes and Association of Membrane-Interacting Peptides in Myelin Membrane Models: A Case of the C-Terminal Peptide of Proteolipid Protein and the Antimicrobial Peptide Melittin.
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway.
Feasibility study design and methods for Project GEMS: Guidelines for Exercise in Multiple Sclerosis.
Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
P2X7 Receptor as a Therapeutic Target.
Quaking Regulates Neurofascin 155 Expression for Myelin and Axoglial Junction Maintenance.
Identification of genetic determinants of the sexual dimorphism in CNS autoimmunity.
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
Progressive cerebral atrophy in neuromyelitis optica.
Pages
« first
‹ previous
…
710
711
712
713
714
715
716
717
718
…
next ›
last »